Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
13.9M
-
Shares change
-
+40.3K
-
Total reported value, excl. options
-
$75.9M
-
Value change
-
+$221K
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$5.50
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2019
17 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q4 2019.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.9M shares
of 47.6M outstanding shares and own 29.21% of the company stock.
Largest 10 shareholders include Blackstone Group Inc (3.37M shares), BVF INC/IL (2.64M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.01M shares), Omega Fund Management, LLC (1.71M shares), Soleus Capital Management, L.P. (1.63M shares), ORBIMED ADVISORS LLC (1.47M shares), RA CAPITAL MANAGEMENT, L.P. (1M shares), COMMONWEALTH EQUITY SERVICES, LLC (21K shares), RENAISSANCE TECHNOLOGIES LLC (12.8K shares), and CIBC World Markets Inc. (10.1K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.